Allergic bronchopulmonary aspergillosis after infliximab therapy for sarcoidosis: A potential mechanism related to T-helper cytokine balance

Chest

Volumn 135, Issue 5, 2009, Pages 1358-1359

  Judson, Marc A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Allergic bronchopulmonary aspergillosis; Cytokine; Infliximab; Sarcoidosis

Indexed keywords

CYTOKINE; HYDROXYCHLOROQUINE; INFLIXIMAB; MINOCYCLINE; PREDNISONE;

ADULT; ARTICLE; BLOOD ANALYSIS; BRONCHOPULMONARY ASPERGILLOMA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DYSPNEA; EPISTAXIS; HUMAN; LOW DRUG DOSE; LUNG FUNCTION TEST; LYMPHADENOPATHY; LYMPHOCYTE; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SARCOIDOSIS; TH2 CELL; THORAX RADIOGRAPHY; UPPER RESPIRATORY TRACT; WHEEZING;

EID: 65949083747     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-2106     Document Type: Article

References (12)

1. Baughman RP, Drent M, Kavuru M, et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 2006; 174:795-802 (Pubitemid 44511661)
2. Judson MA, Baughman RP, Costabel U, et al. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J 2008; 31:1189-1196
3. Doty JD, Mazur JE, Judson MA. Treatment of sarcoidosis with infliximab. Chest 2005; 127:1064-1071 (Pubitemid 40775543)
4. Fehrenbach H, Zissel G, Goldmann T, et al. Alveolar macrophages are the main source for tumour necrosis factor-α in patients with sarcoidosis. Eur Respir J 2003; 21:421-428
5. Zissel G, Muller-Quernheim J. Sarcoidosis: historical perspective and immunopathogenesis (part I). Respir Med 1998; 92:126-139 (Pubitemid 28116229)
6. Vamvouris T, Hadi S. A review of the treatment of psoriasis with infliximab. Rev Recent Clin Trials 2006; 1:201-205
7. Osterman MT, Lichtenstein GR. Infliximab in fistulizing Crohn's disease. Gastroenterol Clin North Am 2006; 35:795-820
8. Toussirot E, Wendling D. The use of TNF-α blocking agents in rheumatoid arthritis: an update. Expert Opin Pharmacother 2007; 8:2089-2107 (Pubitemid 47505587)
9. Chan JL, Davis-Reed L, Kimball AB. Counter-regulatory balance: atopic dermatitis in patients undergoing infliximab infusion therapy. J Drugs Dermatol 2004; 3:315-318
10. Patterson R, Greenberger PA, Halwig JM, et al. Allergic bronchopulmonary aspergillosis: natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med 1986; 146:916-918
11. Holt PG, Clough JB, Holt BJ, et al. Genetic "risk" for atopy is associated with delayed postnatal maturation of T-cell competence. Clin Exp Allergy 1992; 22:1093-1099
12. Kurup VP, Grunig G, Knutsen AP, et al. Cytokines in allergic bronchopulmonary aspergillosis. Res Immunol 1998; 149:466-477 (Pubitemid 28372463)